Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

A Highly Selective and Orally Bioavailable CK1α Molecular Glue Degrader Targets B-Cell Lymphoma Cells

Ran Kong, Shi Feng, Cong Wang, Qingbo Hao, Yu Zhang, Jingjing Han, Xiaoyu Xie, Haiyang Wang, Jan Elsner, Derek Mendy, Michael Haughey, Paul Krenitsky, Veronique Plantevin-Krenitsky, Patrick Papa, Frank Mercurio, Weilin Xie, Xiangxiang Zhou

Blood (2024) 144 (Supplement 1): 956.

https://doi.org/10.1182/blood-2024-208315

Published: 2024

Journal Articles

The Treatment Pathways, Patient Characteristics and Outcomes in Patients with CD30-Expressing Lymphoma from China: A Multi-Center, Non-Interventional, Retrospective Study

Yi Miao, Wenyu Li, Kaiyang Ding, Fei Li, Xiaojing Yan, Xiaoxi Zhou, Caixia Li, Guohui Cui, Liqun Zou, Bing Xiu, Xiangxiang Zhou, Liansheng Zhang, Fuling Zhou, Hongmei Jing, Jianli Wang, Ziheng Guo, Jianyong Li

Blood (2024) 144 (Supplement 1): 6372.

https://doi.org/10.1182/blood-2024-201339

Published: 2024

Journal Articles

Causal Relationship between Gut Microbiota, Derived Metabolites, and Diffuse Large B-Cell Lymphoma: A Two-Sample Mendelian Randomization Study

Ganyu Feng, Guangcai Zhong, Cong Wang, Ran Kong, Jianhong Wang, Xiangxiang Zhou

Blood (2024) 144 (Supplement 1): 6274.

https://doi.org/10.1182/blood-2024-209446

Published: 2024

Journal Articles

ST6GALNAC4 Promotes Diffuse Large B-Cell Lymphoma Progression Via Mediating Sialylation of Bmpr-1B at Thr24

Yu Zhang, Cong Wang, Tiange Lu, Ran Kong, Liemei Lv, Mei Ding, Xiangxiang Zhou

Blood (2024) 144 (Supplement 1): 833.

https://doi.org/10.1182/blood-2024-210107

Published: 2024

Journal Articles

Comprehensive Analysis of Sialylation-Related Signature and Development of a Novel Prognostic Model in Diffuse Large B-Cell Lymphoma

Ran Kong, Cong Wang, Guangcai Zhong, Ganyu Feng, Jiarui Liu, Yang Han, Xiangxiang Zhou

Blood (2024) 144 (Supplement 1): 6241.

https://doi.org/10.1182/blood-2024-199162

Published: 2024

Journal Articles

PRPS2 Facilitates the Tumorigenesis of Diffuse Large B-Cell Lymphoma By Promoting Fatty Acid β-Oxidation

Liemei Lv, Ran Kong, Yu Zhang, Cong Wang, Guangcai Zhong, Yujie Jiang, Kang Lu, Tiange Lu, Xiangxiang Zhou

Blood (2024) 144 (Supplement 1): 2779.

https://doi.org/10.1182/blood-2024-207576

Published: 2024

Journal Articles

Association of Vaccination and Current Immunotherapy with COVID-19 Outcome in Patients with Follicular Lymphoma: A Retrospective Study

Mengyuan He, Xiangxiang Zhou, Yingyue Liu, Yiqing Cai, Linquan Zhan, Xin Wang

Blood (2023) 142 (Supplement 1): 5371.

https://doi.org/10.1182/blood-2023-186034

Published: 2023

Journal Articles

NCAPD3 Prompts Diffuse Large B-Cell Lymphoma Progression through Modulating SIRT1 Expression in H3K9 Monomethylation-Dependent Manner

Tiange Lu, Xiangxiang Zhou, Juan Yang, Yiqing Cai, Mengfei Ding, Xiaomin Chen, Zhuoya Yu, Xiaosheng Fang, Xin Wang

Blood (2023) 142 (Supplement 1): 4363.

https://doi.org/10.1182/blood-2023-184707

Published: 2023

Journal Articles

Lactate-Mediated Histone H3K9 Lactylation Facilitates Tumorigenesis of T-Cell Lymphoma Via Activation of SFXN1 Expression

Zhuoya Yu, Xiangxiang Zhou, Yiqing Cai, Tiange Lu, Mengfei Ding, Xin Wang

Blood (2023) 142 (Supplement 1): 1652.

https://doi.org/10.1182/blood-2023-184663

Published: 2023

Journal Articles

Transcriptomics and Time-Course Proteomics Reveal Pclaf As an Inducer of Resistance Against Pevonedistat in Diffuse Large B-Cell Lymphoma

Tiange Lu, Xiangxiang Zhou, Zhuoya Yu, Linquan Zhan, Bingyu Liu, Mengfei Ding, Xin Wang

Blood (2023) 142 (Supplement 1): 2812.

https://doi.org/10.1182/blood-2023-184590

Published: 2023

Journal Articles

The Characterization and Prognostic Value of Tumor Immune Microenvironment in Diffuse Large B-Cell Lymphoma

Bingyu Liu, Shunfeng Hu, Zhuoya Yu, Tiange Lu, Mengfei Ding, Xiangxiang Zhou, Xin Wang

Blood (2023) 142 (Supplement 1): 4388.

https://doi.org/10.1182/blood-2023-184585

Published: 2023

Journal Articles

A Predictive Model Based on Machine Learning for Early Progression/Relapse of Follicular Lymphoma

Yingyue Liu, Xiangxiang Zhou, Linquan Zhan, Mengyuan He, Tiange Lu, Xin Wang

Blood (2023) 142 (Supplement 1): 1685.

https://doi.org/10.1182/blood-2023-185742

Published: 2023

Journal Articles

Identification of Pyroptosis-Related Signature and Development of a Novel Prognostic Model in Diffuse Large B-Cell Lymphoma

Liemei Lv, Yu Zhang, Yiqing Cai, Zhuoya Yu, Xueling Ge, Xiaosheng Fang, Cong Wang, Ran Kong, Xin Wang, Xiangxiang Zhou

Blood (2022) 140 (Supplement 1): 3589–3590.

https://doi.org/10.1182/blood-2022-162939

Published: 2022

Journal Articles

Orelabrutinib in Combination with Rituximab and Chemotherapy for Newly Diagnosed Aggressive B-Cell Lymphoma: A Multicenter, Single-Arm, Prospective Study

Blood (2022) 140 (Supplement 1): 9544–9545.

https://doi.org/10.1182/blood-2022-169274

Published: 2022

Journal Articles

NAT10 Promotes Tumorigenesis of Diffuse Large B-Cell Lymphoma By ac4C-Dependent Acetylation of SLC30A9

Mengfei Ding, Zhuoya Yu, Yiqing Cai, Tiange Lu, Xiaomin Chen, Xiangxiang Zhou, Xin Wang

Blood (2022) 140 (Supplement 1): 8833–8834.

https://doi.org/10.1182/blood-2022-164599

Published: 2022

Journal Articles

Comprehensive Metabolome Analysis Identified Novel Biomarkers for the Diagnosis and Prognosis of Diffuse Large B-Cell Lymphoma

Yu Zhang, Liemei Lv, Cong Wang, Ran Kong, Tiange Lu, Mei Ding, Yujie Jiang, Xin Wang, Xiangxiang Zhou

Blood (2022) 140 (Supplement 1): 11934–11935.

https://doi.org/10.1182/blood-2022-166421

Published: 2022

Journal Articles

Incidence and Mortality of Second Primary Malignancies after Lymphoma

Yingyue Liu, Yurou Chu, Jiarui Liu, Xueling Ge, Lili Feng, Mei Ding, Peipei Li, Xiangxiang Zhou, Xin Wang

Blood (2022) 140 (Supplement 1): 9569–9570.

https://doi.org/10.1182/blood-2022-166862

Published: 2022

Journal Articles

AT56 Exerts Anti-Tumor Effects in Peripheral T Cell Lymphoma By Regulating HMOX1-Mediated Ferroptosis

Shunfeng Hu, Yiqing Cai, Tiange Lu, Juanjuan Shang, Mengfei Ding, Xiangxiang Zhou, Xin Wang

Blood (2022) 140 (Supplement 1): 7802–7803.

https://doi.org/10.1182/blood-2022-158888

Published: 2022

Journal Articles

Identification of Histone Acetylation Regulator KAT2A As a Potential Prognostic Biomarker in Diffuse Large B-Cell Lymphoma

Zhuoya Yu, Mengfei Ding, Yiqing Cai, Tiange Lu, Xiaomin Chen, Xiangxiang Zhou, Xin Wang

Blood (2022) 140 (Supplement 1): 6464–6465.

https://doi.org/10.1182/blood-2022-164452

Published: 2022

Journal Articles

Global Burden, Risk Factors, and Trends of Non-Hodgkin Lymphoma in 2020 and Projections to 2040: A Population-Based Study

Yurou Chu, Yingyue Liu, Xiaosheng Fang, Yujie Jiang, Mei Ding, Xueling Ge, Dai Yuan, Kang Lu, Peipei Li, Ying Li, Hongzhi Xu, Juan Fan, Xiangxiang Zhou, Xin Wang

Blood (2022) 140 (Supplement 1): 3844–3845.

https://doi.org/10.1182/blood-2022-168779

Published: 2022

NARROW

A Highly Selective and Orally Bioavailable CK1α Molecular Glue Degrader Targets B-Cell Lymphoma Cells

The Treatment Pathways, Patient Characteristics and Outcomes in Patients with CD30-Expressing Lymphoma from China: A Multi-Center, Non-Interventional, Retrospective Study

Causal Relationship between Gut Microbiota, Derived Metabolites, and Diffuse Large B-Cell Lymphoma: A Two-Sample Mendelian Randomization Study

ST6GALNAC4 Promotes Diffuse Large B-Cell Lymphoma Progression Via Mediating Sialylation of Bmpr-1B at Thr24

Comprehensive Analysis of Sialylation-Related Signature and Development of a Novel Prognostic Model in Diffuse Large B-Cell Lymphoma

PRPS2 Facilitates the Tumorigenesis of Diffuse Large B-Cell Lymphoma By Promoting Fatty Acid β-Oxidation

Association of Vaccination and Current Immunotherapy with COVID-19 Outcome in Patients with Follicular Lymphoma: A Retrospective Study

NCAPD3 Prompts Diffuse Large B-Cell Lymphoma Progression through Modulating SIRT1 Expression in H3K9 Monomethylation-Dependent Manner

Lactate-Mediated Histone H3K9 Lactylation Facilitates Tumorigenesis of T-Cell Lymphoma Via Activation of SFXN1 Expression

Transcriptomics and Time-Course Proteomics Reveal Pclaf As an Inducer of Resistance Against Pevonedistat in Diffuse Large B-Cell Lymphoma

The Characterization and Prognostic Value of Tumor Immune Microenvironment in Diffuse Large B-Cell Lymphoma

A Predictive Model Based on Machine Learning for Early Progression/Relapse of Follicular Lymphoma

Identification of Pyroptosis-Related Signature and Development of a Novel Prognostic Model in Diffuse Large B-Cell Lymphoma

Orelabrutinib in Combination with Rituximab and Chemotherapy for Newly Diagnosed Aggressive B-Cell Lymphoma: A Multicenter, Single-Arm, Prospective Study

NAT10 Promotes Tumorigenesis of Diffuse Large B-Cell Lymphoma By ac4C-Dependent Acetylation of SLC30A9

Comprehensive Metabolome Analysis Identified Novel Biomarkers for the Diagnosis and Prognosis of Diffuse Large B-Cell Lymphoma

Incidence and Mortality of Second Primary Malignancies after Lymphoma

AT56 Exerts Anti-Tumor Effects in Peripheral T Cell Lymphoma By Regulating HMOX1-Mediated Ferroptosis

Identification of Histone Acetylation Regulator KAT2A As a Potential Prognostic Biomarker in Diffuse Large B-Cell Lymphoma

Global Burden, Risk Factors, and Trends of Non-Hodgkin Lymphoma in 2020 and Projections to 2040: A Population-Based Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only